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ABSTrACT The present study estimates the economic burden associated with the cases 
of dengue recorded during the 2009 Argentine epidemic. Among the costs considered 
are the medical costs necessary for the treatment of those affected and the opportunity 
costs for those who stopped working or studying because of the disease. In order to 
assess the costs of the disease, at the end of 2009 an ad-hoc survey was carried out in 
201 households where people that had contracted dengue during the 2009 epidemic 
lived. The results allow us to estimate between 26 to 40 million Argentine pesos (6 to 
9 million US dollars) as the total cost of the recorded cases. The regions in the north 
of Argentina bore the highest economic burden of the disease (more than 90% of the 
total burden). For all regions, the social cost of one dengue case accounts for more than 
40% of the average monthly net individual income.
KEy WorDS Dengue; Cost of Illness; Argentina.
rESUMEN El presente estudio estima la carga económica de los casos notifi cados 
de dengue durante la epidemia argentina de 2009. Entre los costos considerados, se 
encuentran los costos médicos para el tratamiento de las personas afectadas y los costos 
de oportunidad de aquellas personas que dejaron de trabajar o estudiar a causa de la 
enfermedad. Para la determinación de los costos, a fi nes de 2009 se llevó a cabo una 
encuesta ad hoc a 201 hogares en los que habitaban personas que habían padecido la 
enfermedad durante la epidemia. Los resultados obtenidos permiten estimar entre los 26 
y los 40 millones de pesos (entre 6 y 9 millones de dólares) el costo total de los casos 
notifi cados. Las regiones del norte argentino son las que habrían soportado la mayor 
carga económica (más del 90% de la carga total). Para todas las regiones, el costo social 
de un caso de dengue representaría más del 40% de la remuneración neta mensual 
promedio de los individuos.
PALABrAS CLAvES Dengue; Costo de Enfermedad; Argentina.
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 INTroDUCTIoN
In recent decades, the incidence of dengue 
has increased dramatically around the world, and 
it is estimated that 2.5 billion people (approxi-
mately two-fifths of the world population) are at 
risk. The Pan American Health Organization es-
timates that each year 50 million dengue-related 
infections are reported worldwide (1).
This disease is endemic in more than 100 
countries in Africa, the Americas, Southeast Asia 
and the Western Pacific. At present, there is not 
only a rise in the number of cases, but explosive 
outbreaks are also becoming more frequent (2). The 
most affected countries in the region are: Brazil, Ec-
uador, Colombia, Paraguay and Venezuela (3).
The outbreak that Argentina faced in 2009 
was considered the worst dengue epidemic in the 
history of the country, due to both the number of 
people affected and the geographic distribution 
of the indigenous cases that exceeded the tradi-
tional endemic channels. According to official 
figures, more than 27,000 cases were recorded, 
and the most affected provinces were Chaco (42% 
of cases), Catamarca (33%), Salta (11%), Jujuy 
(5%), Santa Fe (4%), and Tucumán (2%), although 
there were also indigenous cases recorded in Mis-
iones, Entre Ríos, and the city of Buenos Aires. 
The northern provinces of Argentina were at the 
highest risk: the provinces of Chaco, Catamarca, 
and Salta alone accounted for almost 86% of the 
indigenous cases of dengue recorded during the 
first half of 2009 (4).
The aim of this study is to estimate the ag-
gregate economic burden associated with the 
cases of dengue that occurred during the Ar-
gentine epidemic throughout the first half of the 
year 2009. In this estimate, the cost of the medical 
services needed for the treatment of those affected 
by the disease, as well as the opportunity cost for 
those individuals that discontinued their regular 
activities (like working or attending school) as a 
result of the disease are included. For the cost es-
timate, a social perspective was adopted, in terms 
of the costs to society as a whole, with no dis-
tinction between the different actors responsible 
for those costs (patients, the State, families, etc.).
Cost estimates of the measures taken to 
prevent new cases that were implemented after 
the outbreak of the epidemic (as well as those 
implemented during or before it) are not included. 
The losses that the epidemic could have caused to 
specific economic activities (such as tourism) or to 
the aggregate economic growth of the region or 
country affected – which could both be topics of 
further research – are also not included.
MATErIALS
Quantities 
The cost estimate was carried out taking into 
account the information regarding “quantities” 
of goods and services consumed. This infor-
mation was taken from an ad hoc survey carried 
out during October and November of 2009 in 
the affected zones. This survey allowed for the 
detection of the average duration of the disease 
(differentiating between outpatient and inpatient 
cases), the frequencies of use of medical goods 
and services, and the frequencies related to op-
portunity costs (school days and workdays lost) 
for a sample of the dengue cases that took place 
during the first half of 2009. The target population 
of this analysis was made up of those affected 
by the disease during the epidemic of 2009 in 
Argentina. However, given the difficulties of car-
rying out a survey covering the whole country and 
the absence of a register of cases, the selection of 
the sample was based on the population of one 
endemic region of Argentina, critical in terms of 
the presence of dengue cases during the epidemic, 
and where a thorough register including records 
of the domiciles of the affected people which al-
lowed subsequent contact was also kept. In light of 
these considerations, the city selected was Orán, 
in the province of Salta, one of the cities with the 
highest number of cases in the province and one 
of the most affected in the country, and which has 
a distribution by age groups similar to the age dis-
tribution of the country as a whole. The sample 
was composed of all the notified cases of dengue 
that were registered in the city of Orán during the 
epidemic. It is worth mentioning that this city had 
precise information about the place of residence 
of all the notified cases (which was not true for 
all cases throughout the country). Two hundred 
and one cases of dengue were officially notified 
DENgUE IN ArgENTINA: AN ECoNoMIC ANALySIS of ThE IMPACT of ThE 2009 EPIDEMIC 153
SA
LU
D
 C
O
LEC
TIV
A
, Buenos A
ires, 8(2):151-162, M
ay - A
ugust, 2012
Universidad Nacional de Lanús | Salud Colectiva | English Edition ISSN 2250-5334 | E-ISSN 1851-8265| ISSN-L 1669-2381
in the city of Orán during the period of analysis. 
The people affected were visited, and information 
was gathered by means of a structured question-
naire. To determine the proportions and quantities 
of the services and inputs used, it is assumed that 
in all cases treated by public health care providers 
the clinical protocols recommended by the na-
tional health authority were closely followed. This 
allows for the assumption that there would not be 
significant variations regarding the health care pro-
vided in other areas of the country.
Prices
With the aim of minimizing the problems of 
valuation associated with the existence of sub-
sidies, the prices of medical goods and services 
(drugs, laboratory procedures, medical fees, and 
hospitalization) of the private market were used 
whenever possible. Given the differences in prices 
and salaries throughout Argentina, an attempt was 
made to gather information representative for each 
of the affected regions.
In the case of drugs (paracetamol and ibu-
profen) the prices taken into consideration in-
clude both the suggested retail prices valid at 
a nationwide scale (that match market prices), 
according to the information in the Pharmaceu-
tical Manual [Manual Farmacéutico] (5), and the 
average prices of bids accepted by the National 
Ministry of Health for the drugs distributed as 
part of Programa Remediar, Argentina’s largest 
public drug provision program. Since the pro-
portion of the population treated in the public 
sector in relation to those that received drugs 
from the private sector is unknown, two extreme 
scenarios are used: one in which all the drugs 
used are from private sources (at retail price) and 
one in which all the drugs used are from public 
sources (at public bid prices). In practice, neither 
the prices paid by the State nor the retail prices 
present significant differences between regions 
and/or provinces and, therefore, a single average 
price is considered for all the national territory. 
At the same time, given that the unit prices for 
paracetamol and ibuprofen show considerable 
variation, depending on the commercial brand, 
the presentation of the product, the quantity of 
units per package in the case of retail prices, as 
well as valuations in the public bid prices, av-
erage unit prices were used in this study.
For laboratory practices, the researchers took 
into consideration the prices that the subsystem 
of Social Security uses, based on the information 
of the Unified Biochemical Confederation of the 
Argentine Republic [Confederación Unificada 
Bioquímica de la República Argentina] as well as 
information provided by private laboratories. 
The medical consultations and hospitaliza-
tions were valued according to the prices pro-
vided by different health centers that belong to 
the private sub-sector of the provinces of Chaco, 
Salta and Buenos Aires. In the case of hospitaliza-
tions, prices from different catalogs used by the 
provincial institutions of health insurance were 
also taken into account.
For the assignation of a value to the loss of 
school days, the methodology of similar studies is 
followed, and it is considered that the economic 
value of a school day is at least equal to the cost 
of providing a school day in the public system (6) 
and, being conservative, the value is estimated 
based on the spending per student of public 
schools. At the same time, spending per student 
is estimated taking into account the information 
included in provincial education budgets and the 
number of students enrolled in all educational 
levels in the provinces for the year 2008 (the latest 
information available) (7-13). To update the costs 
to the year 2009, these costs were adjusted taking 
into account the Consumer Price Index [Índice de 
Precios al Consumidor] (14). In turn, to calculate 
the average cost per student, consideration was 
given to the school months and workdays, consid-
ering that this period corresponds to the academic 
year. For this calculation, six jurisdictions were se-
lected, because they constitute places of reference 
in the three regions studied and, at the same time, 
are the jurisdictions in which the majority of cases 
of dengue were notified during the year 2009. 
The selected jurisdictions are: Chaco (Northwest 
region), Salta and Catamarca (Northeast region), 
and Buenos Aires, Santa Fe, and the city of Buenos 
Aires (Central region).
Lastly, the opportunity cost of workdays 
lost is estimated taking into account the income 
information per jurisdiction (for Chaco, Salta, 
Catamarca, Buenos Aires, city of Buenos Aires 
and Santa Fe) for the year 2009, according to the 
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figures of the Ministry of Economy and Public 
Finances (15).
METhoDS
For the purposes of estimating the economic 
burden of the disease, average equations of indi-
vidual costs are approximated for different regions 
of Argentina, which, in turn, are combined with 
official information of recorded dengue cases in 
order to obtain the total costs for each region and 
for the entire country. 
The estimate of the average individual 
medical cost for each region is the result of the 
following expression:
Where:
CMi is the average medical cost for an individual 
infected with the disease in region i; Pi
M is the 
daily price of the drug for region i (unit price of 
drug multiplied by the average daily dosage); FM 
is the average frequency of use of drugs (in days), 
among the cases in which drugs were adminis-
tered, according to the information obtained 
from the ad hoc survey; PrM is the proportion of 
the cases in which drugs were administered for 
treatment, according to the ad hoc survey; Pi
V is 
the average price of a medical consultation for 
region i; FV is the average frequency of medical 
visits, among the people that visited a physician, 
according to the ad hoc survey; PrV is the pro-
portion of patients that visited a physician, ac-
cording to the ad hoc survey; Pi
I is the average 
price per day in cases of hospital admission for 
region i; FI is the average length of hospital stay 
(in days), according to the ad hoc survey; PrI is 
the proportion of the cases of hospital admission, 
according to the ad hoc survey; Pi
L is the average 
price of the laboratory studies for region i; FL 
is the average frequency of laboratory studies 
according to medical standards (measured in 
quantity of standard studies for a case of dengue); 
and PrL is the proportion of cases with symptoms 
of the disease among those that were part of labo-
ratory analysis.
For the estimate of average opportunity costs 
for an individual affected by the disease in each 
region, the following equation applies:
Where:
COi is the average opportunity cost in region i; Pi
S 
is the average salary per day for region i (and ac-
cording to the distribution by age, sex and level of 
education of the cases of dengue in each region); 
FS is the frequency of workdays lost as a result of 
the disease, according to the ad hoc survey (both 
the days lost by the patient and by caregivers are 
included); PrS is the proportion of patients with 
dengue and caregivers that had to miss work, 
according to the ad hoc survey (adjusted by the 
unemployment rate of each region); Pi
E is the 
unit price of a school day lost in region i; FE is 
the frequency of school days lost as a result of the 
disease, according to the ad hoc survey; and PrE is 
the proportion of patients diagnosed with dengue 
that had to miss school, according to the ad hoc 
survey (adjusted for the age structure of the cases 
recorded in each region).
rESULTS
Survey
According to the results of the survey, 91% 
of the notified cases of dengue were outpatients 
and 9% required hospitalization. Among the out-
patient cases, the average duration of the disease 
was 10 days, while the average duration of the 
hospitalized cases was almost 18 days. Inpatients 
indicated that on average they were hospitalized 
more than five days.
Eighty-three percent of the outpatient cases 
indicated having taken medication and 85% re-
ported having visited a doctor at least once. The 
83% of the patients that took medication indicated 
that they did so for an average span of seven days, 
and the 85% of patients that indicated having 
visited a doctor did so on average three times.
The analysis of the loss of workdays and school 
days was carried out for the people that indicated 
at the beginning of the survey that they worked 
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and/or were in school. Among the people that said 
they worked at the beginning of the survey, 82% 
(of those who answered) indicated they had to 
miss work during the period of the disease. Among 
those that missed work, on average eight days were 
lost. On the other hand, 80% of the people that 
were in school (of those who answered) indicated 
they had to be absent, with the average number 
of school days lost being almost nine among these 
respondents.
Costs
The estimate of medical costs was carried 
out taking into account three scenarios according 
to the type of service used. The first scenario as-
sumes the use of the least costly medical alterna-
tives, while the third scenario assumes the use of 
the most expensive.
Given that the cost of drugs represents be-
tween 0.2% and 1% of the total individual av-
erage cost for each scenario (according to whether 
the price paid by the State or the retail price is 
used), only the results obtained when the drugs 
used were valued at the price paid by the State 
are presented in this article. The comparison with 
the retail price can be found in the tables included 
in this section. It should be noted that the equiva-
lences in US dollars included in this text corre-
spond to the official exchange rate of July 2009 
(4.55 Argentine pesos per US dollar).
The first scenario assumes that the individuals 
that used drugs took paracetamol. The inpatient 
cases assume the admissions took place in a general 
hospital ward, and that the laboratory test used for 
the detection of dengue was the IgM or the IgG. 
According to this scenario, the individual medical 
costs, on average, would be 592 Argentine pesos 
(130 USD) for the Central region (city of Buenos 
Aires and provinces of Buenos Aires, Córdoba, 
Entre Ríos, La Pampa, and Santa Fe); 409 Argentine 
pesos (90 USD) for the regions of Northwest 
Argentina (NOA, from the Spanish noroeste ar-
gentino) and Cuyo (Catamarca, La Rioja, Jujuy, 
Salta, Santiago del Estero, Tucumán, Mendoza, San 
Juan, and San Luis); and 466 Argentine pesos (102 
USD) for the region of Northeast Argentina (NEA, 
from the Spanish noreste argentino) (Chaco, Cor-
rientes, Formosa, and Misiones). 
The second scenario assumes that the drug 
used was ibuprofen, that the cases of hospital 
admission took place in a special care unit and 
that the test used for the confirmation of dengue 
was obtained utilizing PCR. According to this sce-
nario, the average individual costs would be 864 
Argentine pesos (190 USD) in the Central region, 
600 Argentine pesos (132 USD) in the NOA and 
Cuyo regions, and 680 Argentine pesos (149 USD) 
in the NEA region. 
The third scenario is different from the second 
only in the type of admission: instead of a special 
care unit, this scenario implies the use of an in-
tensive care unit. In this case, the average indi-
vidual costs would amount to 1473 Argentine 
pesos (324 USD) in the Central region, 714 Ar-
gentine pesos (157 USD) in the NOA and Cuyo 
regions, and 1138 Argentine pesos (250 USD) in 
the NEA region. 
For the estimate of the proportion of people 
affected by the loss of workdays (as a result of the 
disease), the values obtained from the survey (the 
proportion of people that had to stop working) 
were adjusted according to the proportion of 
the people affected in each region in economi-
cally active age groups and to the unemployment 
rate of each region in the year 2009 according 
to the official information (4,16), considering 
that a person affected by the disease, who does 
not work voluntarily or because he/she is unem-
ployed, does not suffer an opportunity cost attrib-
utable to the disease.
The estimates of the opportunity costs due 
to loss of work indicate that, on average, an in-
dividual in the Central region stopped receiving 
(or generating) 542 Argentine pesos (119 USD) 
as a result of the disease. That figure would be 
499 Argentine pesos (110 USD) for individuals 
in the NOA and Cuyo regions, and 468 Ar-
gentine pesos (103 USD) for individuals in the 
NEA region. 
For the estimate of the proportion of the 
population that suffered an opportunity cost due 
to lost school days, the results obtained from 
the survey (people that studied and were forced 
to miss school due to the disease) were adjusted 
taking into account the information about the age 
group to which the people affected in each region 
belong (4), assuming that lost school days can take 
place between 5 to 24 years of age. 
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The estimates of opportunity costs (indi-
viduals on average) for loss of schooling produced 
the following values: 57 Argentine pesos (13 USD) 
for the Central region, 40 Argentine pesos (9 USD) 
for the NOA and Cuyo regions, and 52 Argentine 
pesos (11 USD) for the NEA region.
The average individual costs used as the basis 
for the calculation of medical costs, opportunity 
costs, and total individual costs are presented in 
Table 1. The information about the prices and 
quantities used to estimate the average individual 
costs is also included in the text below:  
a. The different items that make up the costs are 
presented in the first column. In the case of me-
dical costs, the different alternatives of drugs 
and services for each of the scenarios previously 
mentioned are presented. 
b. The second, third and fourth columns show 
the information regarding “quantities,” that 
is to say, the proportion of the population to 
which each item is applied, the frequency of 
use of each good or service, or days of school 
or work lost in the case of opportunity costs. In 
relation to drugs and medical consultations, the 
items apply exclusively to the outpatient cases 
(the daily cost contemplates these items in the 
hospitalization costs for inpatients). Outpatient 
cases accounted for 91% of the cases in the 
sample (proportion 1). This is multiplied by the 
proportion of the patients that used drugs and 
had medical consultations (proportion 2) and 
the number of days drugs were administered 
and the number of medical consultations (fre-
quencies), according to the results of the survey. 
The cases of hospitalizations and laboratory 
tests were treated in a similar fashion. For the 
calculation of the opportunity costs for wor-
kdays lost, proportion 2 – corresponding to the 
ratio of individuals surveyed that answered that 
they had to miss work due to the disease (to the 
total number of people that worked) – is multi-
plied by the proportion 1 which, in turn, is the 
product of: i) the population affected by the di-
sease of economically active age groups in each 
region (according to official information), and 
ii) (1- unemployment rate/100) of each region 
(according to official information). Therefore, in 
this case, proportion 1 is used to adjust for the 
differentials between the age composition of the 
affected population and unemployment rate of 
each region. For the opportunity costs linked to 
the loss of school days, proportion 1 – corres-
ponding to the ratio of the number of affected 
people in the age group 5 to 25 years to the total 
number of affected individuals in each region 
(according to official information) – is multiplied 
by the second proportion, which corresponds to 
the surveyed individuals that answered they had 
missed school days among those that said they 
attended school at the beginning of the survey. 
c. The fifth, sixth and seventh columns show the 
unit prices of medical goods and services, and 
work and school days for each region. It is worth 
mentioning that the price of drugs is expressed 
in days (where the daily dosage is three 500mg 
paracetamol tablets or three 400mg ibuprofen 
tablets). 
d. Finally, the eighth, ninth, and tenth columns 
show the average individual cost for each item, 
including the subtotals for the medical cost, the 
opportunity cost, and the total average individual 
cost (which are the sum of the two subtotals).
It is worth noting that the individual costs esti-
mated in this manner are the sum of weighted av-
erages, where the weight of each item is given by 
the profile of the affected people in the sample, in 
terms of the severity of the case (outpatient or in-
patient), the type of medical good or service used, 
and the age and activity of the affected individual. 
That is to say, although the model of estimation is 
based on average cost (applied to all the officially 
notified cases of dengue), the relative weight of 
the different “profiles” or types of cases and the 
costs associated with those profiles are taken into 
consideration in the calculation, which allows us 
to account for the fact that the cost for one group 
of patients does not necessarily follow a normal 
distribution (because a small number of cases can 
represent a very high cost in terms of medical 
treatment or the duration of the needed treatment, 
while the majority of the cases can be patients 
with much lower cost of treatment). 
With the aim of evaluating the ways in which 
the loss of earnings and the treatment expenses 
would imply a significant economical burden for 
families (when the families are responsible for 
said expenses), the relation between the average 
individual cost of the disease in each region 
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(medical and opportunity costs) and the average 
monthly net income in the same regions was es-
timated (15).
The results of estimating this quotient are rep-
resented in Figure 1, which shows that the cost of 
a case of dengue, for every region and under the 
three scenarios of medical attention considered, 
accounts for more than 40% of the average 
monthly net individual income. The region with 
the highest monthly net cost/income relation is the 
NEA region, followed by the Central and the NOA 
and Cuyo regions. 
Table 2 presents the results of the total cost 
for each region and for the whole country for 
the three evaluated scenarios. According to 
those results, the dengue epidemic that took 
place in Argentina in 2009 implied a cost for 
the Argentine economy as a whole somewhere 
between 26 and 40 million Argentine pesos (be-
tween 6 and 9 million USD, according to the 
exchange rate for the year 2009).
DISCUSSIoN
This study approximated, for the first time in 
Argentina, the economic burden associated with 
the officially notified cases of dengue during the 
epidemic of 2009.
The estimate of the total cost showed that the 
dengue epidemic of 2009 implied an economic 
burden to Argentina somewhere between 26 and 
40 million Argentine pesos at current values (be-
tween 6 and 9 million USD), according to the 
health care scenario considered.
The relative importance of the medical and 
opportunity costs would be similar, although 
these vary depending on the health care scenario 
considered. In the first scenario (which assumes 
the use of the least costly medical services), the 
medical costs account for 43% to 50% of the 
total economic burden, depending on the region 
(Central, Northeast, or Northwest and Cuyo). In 
0.0%
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Figure 1. Impact of the individual cost of dengue in the monthly net income for the 
Central region, the Argentine Northeast (NEA) region and the Argentine Northwest 
(NOA) and Cuyo regions. 2009.
Source: Own elaboration.
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the second scenario, the relative importance fluc-
tuates between 53% and 59%, while in the third 
scenario it fluctuates between 57% and 71%, de-
pending on the region.
The regions in the north of Argentina bore 
the highest economic burden of the disease (more 
than 90% of the total burden of the country), de-
spite the lower unit cost of medical services and 
lower opportunity costs. Although the number of 
cases in the Central region increased during the 
last epidemic, almost 94% of the cases took place 
in the north of the country, which explains the 
high economic burden for the region. 
For all regions, and considering all three sce-
narios of medical attention, the cost of a case of 
dengue accounts for more than 40% of the av-
erage monthly net individual income. The region 
with the highest monthly net cost/income relation 
is the NEA region, followed by the Central and the 
NOA and Cuyo regions.
One of the limitations of this study is the lack 
of information needed to estimate non-medical 
costs such as those related to transportation and 
those associated with being far from one’s place 
of residence as a result of the disease. Losses that 
the dengue epidemic may have caused in specific 
economic activities (such as tourism) or to the ag-
gregate economic growth of the affected region 
were also not taken into account.
On the other hand, since the initial aim of the 
study was to estimate the economic burden of the 
disease specifically associated with the number 
dengue cases that took place during the epidemic 
of 2009, and not the economic burden of the 
dengue fever in a broader sense, the cost of pre-
ventive measures for the disease was not included.
The estimates of quantities (frequency of 
use of services and school or workdays lost) are 
based on the information for a sample of a spe-
cific group of citizens (the population of the city of 
Orán, in the province of Salta). For the estimates 
of costs, estimated average frequencies based on 
the sample were used, and it is assumed that those 
frequencies are representative of the average fre-
quencies of the affected population in the whole 
country. Therefore, the extrapolation implies as-
suming that the averages of disease duration, fre-
quency of the use of medical goods and services, 
and number of school and workdays lost are rela-
tively constant among all regions. While this may 
appear to be a strong assumption, the existing 
evidence for some of those quantities indicates 
that they are relatively constant, even in groups 
of citizens with considerable differences between 
them. According to the estimations of Suaya et al. 
(15), the average duration of the disease among 
the outpatient cases fluctuates between 9 and 12 
days (only one country of the eight Latin American 
and Asian countries analyzed in the study showed 
a longer average duration: 19.6 days for Panama), 
which is very similar to the estimations of this 
study based on the sample information (which 
showed an average duration of 10 days). For the 
inpatient cases of dengue, Suaya et al. show that 
Table 2. Economic cost of dengue for the Central region, the Argentine Northwest (NOA) and Cuyo 
regions, the Argentine Northeast (NEA) region, and the country as a whole.
Region Affected provinces of the region
Total 
cases
Total cost Scenario 1 
(in ARS)
Total cost Scenario 2 
(in ARS)
Total cost Scenario 3 
(in ARS)
Central
Autonomous city of 
Buenos Aires, Provin-
ce of Buenos Aires, 
Córdoba, Entre Ríos, 
Santa Fe
1,625 1,935,458 (1,943,861) 2,376,392 (2,388,763) 3,366,738 (3,379,110)
NOA & Cuyo
Catamarca, La Rioja, 
Jujuy, Salta, Santiago 
del Estero and Tucu-
mán. Mendoza and 
San Luis
14,238 13,499,290 (13,572,912) 16,230,070 (16,338,469) 17,846,442 (17,954,842)
NEA Chaco, Corrientes and Misiones 11,180 11,026,428 (11,084,237) 13,421,990 (13,507,108) 18,545,062 (18,630,180)
Whole country 27,043 26,461,176 (26,601,010) 32,028,451 (32,234,341) 39,758,242 (39,964,132)
Source: Own elaboration.
Note: The values presented correspond to the average purchase price of drugs by the State for the Remediar program, and the value in parantheses is the average retail 
price. Both values are expressed in Argentine pesos. The official exchange rate during July of the year 2009 was 4.55 Argentine pesos per US dollar.
160 TArrAgoNA S, MoNTEvErDE M, MArChIoNI S, CAPorALE J, PErEIro AC, PALACIoS JM
SA
LU
D
 C
O
LE
C
TI
V
A
, B
ue
no
s 
A
ire
s,
 8
(2
):1
51
-1
62
, M
ay
 - 
A
ug
us
t, 
20
12
Universidad Nacional de Lanús | Salud Colectiva | English Edition ISSN 2250-5334 | E-ISSN 1851-8265| ISSN-L 1669-2381
the average duration of the disease, in general, 
fluctuates between 10 and 19 days, while the esti-
mates based on the sample for Orán show an av-
erage duration of almost 18 days. 
Lastly, the methodology used by Suaya et 
al. (15) was employed to estimate the value of a 
school day lost, where spending per student is 
considered. This estimation of the value of student 
enrollment can be seen as an indirect approxi-
mation of the economic (opportunity) cost of the 
resources already invested that are then not used, 
but does not approximate the present value of the 
salaries that could be affected if the loss of school 
days would have an impact, to some extent, on the 
future productivity of the affected students.
In all countries that have outbreaks of dengue, 
there is evidence indicating that the official figures 
underestimate the true number of cases, which 
highlights the necessity of considering expansion 
factors that allow for the realization of more ac-
curate estimates (17). According to previous studies, 
it is estimated that for each inpatient dengue case 
there are 1.6 to 3.2 more cases that should have 
received such care but did not. For the outpatient 
cases of dengue, it is estimated that for each case 
diagnosed, there are between 10 to 27 undiag-
nosed cases (18-20). For the total number of cases 
it is estimated that, on average, for each recorded 
case there are six cases that were not detected by 
the official health statistics (21). Consequently, 
the results obtained in this study are indeed con-
servative, since only the cases that were officially 
reported were taken into account. In effect, if for 
each recorded case three non-recorded cases were 
contemplated, the estimation would show an eco-
nomic burden that would fluctuate between 78 
and 120 million Argentine pesos (17 to 26 million 
USD), and if the aforementioned studies were 
to be considered, these figures would amount to 
between160 and 240 million Argentine pesos (35 
to 53 million USD).
The results obtained show how great the 
burden related to the dengue epidemic that took 
place in Argentina in the year 2009 was for the 
health system and for the society as a whole. 
There is currently an increase in the number 
of cases and in the frequency of the outbreaks in 
the world and in the region. In the early 1990s, 
250,000 cases were recorded in the region of 
the Americas. At the beginning of the present 
decade, 600,000 cases were reported, while in 
the year 2007 alone more than 890,000 cases 
were notified, 26,000 of which were cases of 
hemorrhagic dengue (2).
Given the current tendency, and considering 
the lack of effective prevention campaigns, it is 
possible that dengue fever will continue to pose 
a problem in Argentina. It is known that the risk 
of death for individuals infected with a particular 
strain of dengue increases if they later contract a 
different strain. In light of this situation, the lack 
of effective prevention campaigns would not 
only imply an increase in the number of potential 
cases, but also an increase in the probability of 
more severe cases. This would not only increase 
the economic burden of the disease, but would 
also increase the risk of disability and mortality of 
the affected population. 
The results show, additionally, that studies 
of economic burden should contemplate a broad 
spectrum of costs generated by the disease. While 
the medical cost related to the treatment of the 
affected population accounts for an important 
fraction of the total burden of dengue, this portion 
is not necessarily the most important. The op-
portunity cost associated with the loss of school 
and workdays accounts forms another important 
fraction of the economic burden of disease.
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